Cardiac ultrastructural changes induced by daunorubicin therapy.
about
Doxorubicin cardiomyopathyChemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative StressCardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectantsNaproxen aggravates doxorubicin-induced cardiomyopathy in rats.Effects of cardiac-restricted overexpression of the A(2A) adenosine receptor on adriamycin-induced cardiotoxicityReduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction.Neoplasms involving the heart, their simulators, and adverse consequences of their therapy.Cardiac lesions induced by chemicals.Anthracycline treatment and ventricular remodeling in left ventricular assist device patients.Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicityIntracytoplasmic junctions in cardiac muscle cells.Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits.Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy.MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2.Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brainCoenzyme q10 for prevention of anthracycline-induced cardiotoxicity.Nuclear magnetic resonance study of high-energy phosphate stores in models of adriamycin cardiotoxicity.Cardioprotective effect of Vedic Guard against doxorubicin-induced cardiotoxicity in rats: A biochemical, electrocardiographic, and histopathological studyMitigating effects of ICRF-159 (razoxane) on a daunomycin-induced cardiomyopathy in mice.Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicin.Lipid lowering: an important factor in preventing adriamycin-induced heart failure.Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction and survival in murine doxorubicin cardiotoxicity.Nucleolar organizer regions in cardiac lesions induced by doxorubicin.Breast cancer treatment and adverse cardiac events: what are the molecular mechanisms?.
P2860
Q24606920-AC7EADBA-C4E5-4635-AC27-15463EA98610Q26780547-F01F2866-30BB-46D2-AB5A-F04A9A9B2844Q28367065-99F4EF1A-B7C3-4824-93EF-E801F60C7B20Q33913113-A5453CBD-C47C-4215-B79E-5A52F8759A4EQ33917116-FA0AF17B-951B-471B-A007-C9066F717AC6Q34092826-F93B06EA-C1AE-4BD6-964D-64B847261941Q34191677-896BF7AE-36DF-48D8-A992-A150EAA594ADQ35132685-10CE0153-60DC-4579-ACC8-D120B29D3034Q35246219-16696FC2-ED5A-4A5C-BCA3-AB3A4C1CB9D9Q35858475-BD5F61B7-68AF-4921-B0DF-C0ED5456EDB9Q35875212-3D3E0D9A-583C-4AD4-B576-90D1C9AEF93BQ35875568-6E948F72-8D64-425B-91E2-7FCBB2C5EE00Q35877990-8AA5A1EB-C858-4546-86D1-ED1FCF2CC478Q35902403-EEC56E4B-4C8E-436B-ACBD-00298250E739Q36022217-A8BE5CD8-E7DE-4915-AC03-025227848FAEQ36077653-F0BC055A-429F-40E4-BC5D-0245722EFBC1Q36136382-1B153F9D-544C-4E98-86F4-840710B6D82FQ41480726-DA64618C-18EC-446D-B545-C679B2DDDF3DQ41764601-1FA8CC39-7AA9-4B37-8AF4-C494A4955225Q42265214-7A97F455-FDB1-423D-8B51-5F89CD974EB8Q42708190-2BBB4CAB-FA03-4346-B658-03F34A503FB7Q42839365-4E31E53A-CFD2-4E94-A2CF-CB135DA27A5BQ42961337-252EF6AF-1096-4C85-B605-ED1905D5807BQ43753789-EE7D58DF-6D8A-47C0-83F7-606EF456187EQ54489633-4CF8868E-3C81-482E-BB7C-AF1FFA7FCD37
P2860
Cardiac ultrastructural changes induced by daunorubicin therapy.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh
1973年學術文章
@zh-hant
name
Cardiac ultrastructural changes induced by daunorubicin therapy.
@en
Cardiac ultrastructural changes induced by daunorubicin therapy.
@nl
type
label
Cardiac ultrastructural changes induced by daunorubicin therapy.
@en
Cardiac ultrastructural changes induced by daunorubicin therapy.
@nl
prefLabel
Cardiac ultrastructural changes induced by daunorubicin therapy.
@en
Cardiac ultrastructural changes induced by daunorubicin therapy.
@nl
P2093
P1433
P1476
Cardiac ultrastructural changes induced by daunorubicin therapy
@en
P2093
E S Henderson
V J Ferrans
W C Roberts
P304
P356
10.1002/1097-0142(197310)32:4<771::AID-CNCR2820320407>3.0.CO;2-A
P407
P577
1973-10-01T00:00:00Z